A Phase 1 Study of BB102 in Participants With Advanced Solid Tumors
Condition(s):Advanced Solid TumorLast Updated:February 20, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Advanced Solid TumorLast Updated:February 20, 2024Recruiting
Condition(s):Advanced Solid TumorsLast Updated:March 30, 2023Terminated
Condition(s):Advanced Solid TumoursLast Updated:July 25, 2022Completed
Condition(s):Advanced Solid Tumors; Excluding Breast CancerLast Updated:December 21, 2020Completed
Condition(s):Advanced Solid TumorsLast Updated:September 28, 2023Recruiting
Condition(s):Advanced Solid Tumors; Triple Negative Breast CancerLast Updated:January 3, 2024Active, not recruiting
Condition(s):Advanced Solid TumorsLast Updated:February 9, 2024Completed
Condition(s):Advanced Solid TumorLast Updated:March 8, 2024Recruiting
Condition(s):Advanced Solid TumorsLast Updated:December 30, 2022Recruiting
Condition(s):Advanced Solid TumorLast Updated:January 20, 2022Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.